cytarabine has been researched along with apyrase in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aroua, N; Azuaje, F; Bardotti, M; Bellvert, F; Boet, E; Bonnefoy, N; Bosc, C; de Toni, F; Farge, T; Gandarillas, S; Ghisi, M; Gotanègre, M; Gwilliam, R; Hosseini, M; Jarrou, L; Joffre, C; Kaoma, T; Larrue, C; Laurent, C; Mazed, F; Mouchel, PL; Nicolau-Travers, ML; Nicot, N; Picard, M; Portais, JC; Récher, C; Sabatier, M; Saland, E; Sarry, JE; Stuani, L; Syrykh, C; Tamburini, J; Vergez, F | 1 |
1 other study(ies) available for cytarabine and apyrase
| Article | Year |
|---|---|
Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.
Topics: Antigens, CD; Apyrase; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitochondria | 2020 |